The effectiveness of zofenopril in patients with cardiovascular disease | Zendy

V G Kukes | Zendy; G S Anikin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The effectiveness of zofenopril in patients with cardiovascular disease

Author(s) -

V G Kukes,

G S Anikin

Publication year - 2014

Publication title -

systemic hypertension

Language(s) - English

Resource type - Journals

eISSN - 2542-2189

pISSN - 2075-082X

DOI - 10.26442/sg29028

Subject(s) - renin–angiotensin system , disease , medicine , pharmacology , angiotensin converting enzyme , aldosterone , blood pressure

Hyperactivity of the renin-angiotensin-aldosterone system plays an important role in the pathogenesis of any cardiovascular disease. Angiotensin - converting enzyme inhibitors are the main drugs among many medicines influencing the activity of the renin-angiotensin-aldosterone system, and these inhibitors have a wide range of beneficial effects. The presence of the sulfhydryl group in a molecule of angiotensin-converting enzyme inhibitor (zofenopril) determines the number of unique properties of this drug. Recent results have been showing the effectiveness of treatment in case of combined cardiovascular disease. This article presents the results of the studies showing the efficacy and safety of zofenopril.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research